Na<sub>V</sub>channel variants in patients with painful and nonpainful peripheral neuropathy
Article 2017 en
Authors
SW
Samir Wadhawan
SP
Saumya Pant
RG
Ryan Golhar
Abstract
1 min read
These results suggest that identification of a genetically defined subpopulation for testing of Na<sub>V</sub>1.7 inhibitors in patients with peripheral neuropathy is unlikely and that additional factors, beyond expression of previously reported disease "mutations," are more important for the development of painful neuropathy than previously discussed.
Larysa Sanchez, Xavier Leleu, Jennifer L. Beaumont, Hailin Yu, Stacie Hudgens, Maryana Simonova, Holger W. Auner, Hang Quach, Sosana Delimpasi, Ivan Špıčka, Luděk Pour, Iryna Kriachok, Meletios A Dimopoulos, Ganna Usenko, Roman Hájek, Reuben Benjamin, Dinesh Kumar Sinha, Christopher P. Venner, Thomas Illmer, Mamta Garg, Don A. Stevens, Sundar Jagannath,
Paul Huchedé, Swann Meyer, Clément Berthelot, Maud Hamadou, Adrien Bertrand‐Chapel, Andria Rakotomalala, Line Manceau, Julia Tomine, Nicolas Lespinasse, Paul Lewandowski, Martine Cordier–Bussat, Laura Broutier, Aurélie Dutour, Isabelle Rochet, Jean Yves Blay, Cyril Dégletagne, Valéry Attignon, Angel Montero-Carcaboso, Marion Le Grand, Eddy Pasquier, Alexandre Vasiljevic, Pascale Gilardi‐Hebenstreit, Samuel Meignan,
Paul Huchedé, Swann Meyer, Clément Berthelot, Maud Hamadou, Adrien Bertrand‐Chapel, Andria Rakotomalala, Line Manceau, Julia Tomine, Nicolas Lespinasse, Paul Lewandowski, Martine Cordier–Bussat, Laura Broutier, Aurélie Dutour, Isabelle Rochet, Jean Yves Blay, Cyril Dégletagne, Valéry Attignon, Angel Montero-Carcaboso, Marion Le Grand, Eddy Pasquier, Alexandre Vasiljevic, Pascale Gilardi‐Hebenstreit, Samuel Meignan,
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.